HbA1c Testing Device Market Set to Surge with 10.6% CAGR Through 2033 | DataM Intelligence

The HbA1c Testing Device Market, valued at US$ 2.01 billion in 2024, is projected to hit US$ 5.69 billion by 2033, growing at a CAGR of 10.6%.

NEW YORK, NY, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Market Overview :
The HbA1c Testing Device Market is witnessing robust expansion, driven by the rising burden of diabetes and growing emphasis on early diagnosis and disease monitoring. Valued at US$ 2.01 billion in 2024, the market is projected to reach US$ 5.69 billion by 2033, reflecting a CAGR of 10.6% during 2025–2033. Hemoglobin A1c (HbA1c) testing devices are vital tools in monitoring long-term glucose control in diabetic patients, and the demand is increasing due to the rising inclination toward home healthcare and point-of-care testing.

Market Drivers:

Rising Global Diabetes Incidence: With over 537 million adults living with diabetes worldwide, regular HbA1c testing is critical for effective disease management.

Growing Popularity of Point-of-Care Devices: Portable analyzers are gaining traction due to faster results and convenience in home settings.

Supportive Government Screening Programs: Countries are ramping up initiatives to detect and manage diabetes at an early stage.

Increasing Healthcare Spending in Emerging Markets: Countries like India, China, and Brazil are investing in diagnostic technologies.

Technological Advancements: The incorporation of smart technologies and wireless connectivity in HbA1c devices is enhancing testing precision and streamlining data management for both patients and healthcare providers.

Expanding Geriatric Population: Older individuals are more vulnerable to Type 2 diabetes, increasing demand for regular HbA1c monitoring.

Get Premium Sample Report : https://www.datamintelligence.com/download-sample/hba1c-testing-device-market

Market Key Players

The competitive landscape of the HbA1c testing device market is dominated by a few global giants. Key players include:

Bio-Rad Laboratories, Inc.

Abbott

F. Hoffmann-La Roche Ltd.

Siemens Healthineers AG

Danaher Corporation

EKF Diagnostics Holdings PLC

Arkray, Inc.

Trinity Biotech plc

Polymer Technology Systems, Inc.

Transasia Biomedicals Ltd.

These companies are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their global footprint.

Market Segmentation

By Technology:

Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Others

By Device Type:

Bench-top Devices
Handheld Devices

By End User:

Hospitals
Diagnostic Laboratories
Home Care Settings
Research Institutions

Latest News of USA:

In April 2024, the CDC partnered with Walgreens to launch a free HbA1c testing campaign across underserved communities.

Abbott secured FDA approval for its latest HbA1c test kit, which includes integrated digital tracking capabilities for improved patient monitoring.

Danaher Corporation announced a US$100 million expansion in its diagnostic manufacturing facilities in Massachusetts.

Latest News of Japan:

Arkray, Inc. launched a compact, portable HbA1c analyzer tailored for Japan's aging population.

The Japanese Ministry of Health announced new reimbursement policies for home-based HbA1c testing, effective late 2024.

Trinity Biotech signed a distribution agreement with a Japanese pharmaceutical giant to expand local access to its HbA1c devices.

Key 2024 Developments :

Bio-Rad introduced an AI-enabled HbA1c analyzer for large diagnostic labs.

Siemens Healthineers launched a cloud-connected bench-top HbA1c system.

EKF Diagnostics upgraded its Quo-Test platform for faster result delivery.

Roche revealed that its HbA1c testing modules are now compatible across multiple platforms, enhancing flexibility and usability in clinical settings.

Polymer Technology Systems rolled out a Bluetooth-enabled HbA1c test device.

Conclusion

As diabetes becomes a major public health concern worldwide, the demand for accurate and accessible HbA1c testing devices is poised to grow steadily. The market's future will be shaped by technological innovations, home-based testing trends, and increased awareness of preventive healthcare. With strategic moves by key players and supportive healthcare policies, the HbA1c Testing Device Market is on track for sustained growth, playing a critical role in diabetes management across the globe.

Related Reports :

Neurorehabilitation Devices Market outlook (2024-2031)

Catheter Stabilization Devices Market Forecast (2024-2031)

Sai Kumar
DataM Intelligence 4market Research LLP
+1 877-441-4866
email us here
Visit us on social media:
LinkedIn
X